VISEN Pharmaceuticals (HKG:2561)
10.09
-0.41 (-3.90%)
Nov 20, 2026, 3:48 PM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 1.1 billion as of November 20, 2026. It is the 22,295th most valuable company in the world and the 1,050th biggest in Hong Kong. Its market cap has decreased by 67.17% in one year.
Market Cap
1.10B
Enterprise Value
722.86M
Revenue
39.32M
Global Rank
Country Rank
#1,050 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 1.10B, a decrease of -84.67%. That is a compound annual growth rate of -67.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.10B | -67.99% |
| Dec 31, 2025 | 3.44B | -52.13% |
| Mar 21, 2025 | 7.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hua Medicine (Shanghai) | 2.10B |
| CPBIO Holding Company | 1.95B |
| CF PharmTech | 1.90B |
| Jacobson Pharma Corporation | 1.80B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.60B |
| Golden Throat Holdings Group Company | 1.42B |
| Dawnrays Pharmaceutical (Holdings) | 1.33B |
| JBM (Healthcare) | 1.23B |